• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Ellipse Technologies Inc.

Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017

December 15, 2017 By Fink Densford

Vascular Dynamics said early this month it tapped former NuVasive Inc. (NSDQ:NUVA) exec and Ellipse Technologies CEO Ed Roschak as its new president and chief executive. Prior to joining Mountain View, Calif.-based Vascular Dynamics, Roschak served as prez and CEO of Ellipse Technologies, which he saw through a $410 million acquisition by NuVasive. He then took up […]

Filed Under: Business/Financial News Tagged With: Aptus EndoSystems Inc., Asante Solutions, Avanos Medical (formerly Halyard Health), Boston Scientific, Cutera Inc., Ellipse Technologies Inc., Encision Inc., Genoptix Inc., Hologic, Johnson and Johnson, Novartis, Nuvasive, Presbia, regentys, tandemdiabetes, Tria Beauty Inc., vasculardynamics, Ventus Medical Inc., Vermillion Inc., wishbonemedical

NuVasive in $410m deal to acquire Ellipse Technologies

January 6, 2016 By Brad Perriello

NuVasive Inc. (NSDQ:NUVA) and Ellipse Technologies said yesterday that they inked a deal worth up to $410 million for NuVasive to acquire Ellipse and its adjustable orthopedic implants. Aliso Viejo, Calif.-based Ellipse, which registered a $75 million initial public offering last October, has a pair of orthopedic surgery devices already on the market: The Magec-Eos spinal bracing and […]

Filed Under: Mergers & Acquisitions, Orthopedics, Spine Tagged With: Ellipse Technologies Inc., Nuvasive

Ellipse Technologies files for $75m IPO

October 19, 2015 By Brad Perriello

Ellipse Technologies last week registered for an initial public offering that could fetch as much as $75 million for its magnetically adjustable orthopedic implants. Aliso Viejo, Calif.-based Ellipse has a pair of orthopedic surgery devices already on the market, the Magec-Eos spinal bracing and distraction system for early-onset scoliosis, and the Precice limb-lenthening system for treating […]

Filed Under: Funding Roundup, Initial Public Offering (IPO), Orthopedics Tagged With: Ellipse Technologies Inc.

Stryker eliminates international prez Subrahmanian’s role | Personnel Moves

September 18, 2015 By Brad Perriello

Stryker (NYSE:SYK) said yesterday that it’s eliminating the role of international president held by Ramesh Subrahmanian as it reorganizes its overseas business. After Subrahmanian’s departure, effective Dec. 31, he’s slated to stay on until March 31, 2016, as an advisor, Stryker said in a regulatory filing. International sales were down across the board during Stryker’s […]

Filed Under: Business/Financial News Tagged With: Accuray Inc., Alphabet (Google), Elixir Medical Corp., Ellipse Technologies Inc., Endologix, Eos Imaging, Event Cardio Group, IBM, National Institute of Mental Health, Nuvasive, Personnel Moves, PureTech, ReWalk Robotics, Stryker, Volcano Corp.

Ellipse Technologies lands FDA clearance for limb-lengthening device

February 10, 2014 By Chris Walker Leave a Comment

Ellipse Technologies lands FDA clearance for limb lengthening device

Ellipse Technologies said it secured clearance from the FDA for its Precice 2 limb-lengthening system.

Irvine, Calif.-based Ellipse makes spinal and orthopedic devices. The devices are adjustable without an invasive procedure and mainly come in the form of remote-controlled implants.

Filed Under: Food & Drug Administration (FDA), Implants, News Well, Orthopedics, Regulatory/Compliance Tagged With: Ellipse Technologies Inc.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy